000919.SZ
金陵药业
SZSE · Healthcare · C 制造业 · CN
CNY 6.51
−1.96%Aug 28, 2026, 08:25 UTC
Jinling Pharmaceutical announced its first-half 2026 results: revenue of 1.584 billion yuan, down 1.04% year-on-year; net profit attributable to shareholders of 50.3825 million yuan, up 4.24% year-on-year.
Jul 31, 2026, 08:59 UTC
Jinling Pharmaceutical's Fuzhou Meifeng Pharmaceutical Factory received an acceptance notice from the National Medical Products Administration for its marketing authorization application for ferric carboxymaltose injection.
Source: